Efficacy and safety of exenatide (ITCA 650) versus available GLP-1 receptor agonists in patients with type 2 diabetes mellitus: A phase IIIb, pragmatic randomised controlled study
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Jan 2018 New trial record
- 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation